scispace - formally typeset
J

Jie Ran

Researcher at Shandong Normal University

Publications -  30
Citations -  731

Jie Ran is an academic researcher from Shandong Normal University. The author has contributed to research in topics: Cilium & Ciliogenesis. The author has an hindex of 14, co-authored 25 publications receiving 557 citations. Previous affiliations of Jie Ran include Nankai University.

Papers
More filters
Journal ArticleDOI

Deacetylation of α-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly.

TL;DR: Evidence is provided that HDAC6-mediated deacetylation of α-tubulin and cortactin is critical for its induction of ciliary disassembly, and the importance of reversible acetylation in regulating ciliary homeostasis is underscored.
Journal ArticleDOI

CYLD regulates spindle orientation by stabilizing astral microtubules and promoting dishevelled-NuMA-dynein/dynactin complex formation

TL;DR: It is demonstrated that cylindromatosis (CYLD) regulates spindle orientation via its dual functions as a microtubule-associated protein and deubiquitinase, and uncovered CYLD as an important player in the orientation of the mitotic spindle and cell division.
Journal ArticleDOI

CYLD mediates ciliogenesis in multiple organs by deubiquitinating Cep70 and inactivating HDAC6

TL;DR: It is shown that cylindromatosis (CYLD), a tumor suppressor protein harboring deubiquitinase activity, plays a critical role in the assembly of both primary and motile cilia in multiple organs and is identified as a crucial regulator of this process.
Journal ArticleDOI

HDAC6 Deacetylase Activity Is Critical for Lipopolysaccharide-Induced Activation of Macrophages

TL;DR: In this article, the authors identify a role for histone deacetylse 6 (HDAC6) in lipopolysaccharide (LPS)-induced macrophage activation and show that suppression of HDAC6 activity significantly restrains LPS-induced activation of macrophages and production of pro-inflammatory cytokines.
Journal ArticleDOI

Targeted inhibition of histone deacetylase 6 in inflammatory diseases.

TL;DR: Recent findings highlighting the critical roles of HDAC6 in a variety of inflammatory diseases are reviewed, and the therapeutic potential ofHDAC6 inhibitors in these settings are discussed.